SciELO - Scientific Electronic Library Online

vol.111 issue3 author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand



Related links

  • On index processCited by Google
  • On index processSimilars in Google


SAMJ: South African Medical Journal

On-line version ISSN 2078-5135
Print version ISSN 0256-9574

SAMJ, S. Afr. med. j. vol.111 n.3 Pretoria Mar. 2021


15. Zhou P, Liu Z, Chen Y, Xiao Y, Huang X, Fan X-G. Bacterial and fungal infections in COVID-19 patients: A matter of concern. Infect Control Hosp Epidemiol 2020;41(9):1124-1125.        [ Links ]

16. Rutsaert L, Steinfort N, van Hunsel T, et al. COVID-19-associated invasive pulmonary aspergillosis. Ann Intensive Care 2020;10(1):1-4.        [ Links ]

17. Mohamed A, Rogers TR, Talento AF. COVID-19 associated invasive pulmonary aspergillosis: Diagnostic and therapeutic challenges. J Fungi 2020;6(3):115.        [ Links ]

18. Alp E, Voss A. Ventilator associated pneumonia and infection control. Ann Clin Microbiol Antimicrob 2006;5(1):7.        [ Links ]

19. Schauwvlieghe AF, Rijnders BJ, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: A retrospective cohort study. Lancet Respir Med 2018;6(10):782-792.        [ Links ]

20. Koehler P, Cornely OA, Böttiger BW, et al COVID-19 associated pulmonary aspergillosis. Mycoses 2020;63(6):528-534.        [ Links ]

21. Koehler P, Bassetti M, Kochanek M, Shimabukuro-Vornhagen A, Cornely OA. Intensive care management of influenza-associated pulmonary aspergillosis. Clin Microbiol Infect 2019;25(12):1501-1509.        [ Links ]

22. Buil JB, Meijer EF, Denning DW, Verweij PE, Meis JF. Burden of serious fungal infections in the Netherlands. Mycoses 2020;63(6):625-631.        [ Links ]

23. Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA 2020;323(20):2085-2086.        [ Links ]

24. Gangneux J-P, Bougnoux M-E, Dannaoui E, Cornet M, Ralph ZJ. Invasive fungal diseases during COVID-19: We should be prepared. J Mycol Med 2020;30(2):100971.        [ Links ]

25. Ding Q, Lu P, Fan Y, Xia Y, Liu M. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol 2020;92(9):1549-1555.        [ Links ]

26. Verweij PE, Gangneux J-P, Bassetti M, et al. Diagnosing COVID-19-associated pulmonary aspergillosis. Lancet 2020;1(2):E53-E55.        [ Links ]

27. NHS. Prioritisation/deferral of pathology laboratory work (in light of SARSCoV-2 (COVID19) epidemic). 2020. (accessed 18 August 2020).         [ Links ]

28. Govender NP. Why we should take fungal infections more seriously. National Institute for Communicable Diseases, 4 October 2018. (accessed 30 June 2020).         [ Links ]

29. Gao H-N, Lu H-Z, Cao B, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 2013;368(24):2277-2285.        [ Links ]

30. Hwang DM, Chamberlain DW, Poutanen SM, Low DE, Asa SL, Butany J. Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol 2005;18(1):1-10.        [ Links ]

31. Ahmadi A, Ardehali SH, Beigmohammadi MT, et al. Invasive candidiasis in intensive care unit: Consensus statement from an Iranian panel of experts, July 2013. JRSM Open 2014;5(3):1-10.        [ Links ]

32. Bassetti M, Garnacho-Montero J, Calandra T, et al. Intensive care medicine research agenda on invasive fungal infection in critically ill patients. Intensive Care Med 2017;43(9):1225-1238.        [ Links ]

33. Zuo T, Zhan H, Zhang F, et al Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology 2020 (epub 26 June 2020).        [ Links ]

34. Schwartz IS, Boyles TH, Kenyon CR, Hoving JC, Brown GD, Denning DW. The estimated burden of fungal disease in South Africa. S Afr Med J 2019;109(11):885-892.        [ Links ]

35. Rajasingham R, Smith RM, Park BJ, et al Global burden of disease of HIV-associated cryptococcal meningitis: An updated analysis. Lancet Infect Dis 2017;17(8):873-881.        [ Links ]

36. Patel M, Shackleton JT, Coogan MM. Effect of antifungal treatment on the prevalence of yeasts in HIV-infected subjects. J Med Microbiol 2006;55(9):1279-1284.        [ Links ]

37. National Institute for Communicable Diseases. The impact of COVID-19 public health measures on diagnosis of advanced HIV disease, cryptococcal antigenaemia and cryptococcal meningitis in South Africa. 15 June 2020. (accessed 20 August 2020).         [ Links ]

38. Zamparini J, Venturas J, Shaddock E, et al. Clinical characteristics of the first 100 COVID-19 patients admitted to a tertiary hospital in Johannesburg, South Africa. Wits J Clin Med 2020;2(2):105-114.        [ Links ]

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License